Moderna, Pfizer and Novavax are slated to roll out new vaccines targeting XBB.1.5 within weeks, pending approvals from the FDA.
UBS upgrades this restaurant tech stock that can rally nearly 40%
The bank upgraded shares to buy from neutral in a Wednesday note.
UBS downgrades this digital payments stock, slashes price target
UBS downgraded shares to neutral from buy, citing a limited growth outlook
EU lists Alphabet, Amazon, Meta and three other tech giants as ‘gatekeepers’ under strict competition rules
The European Union on Wednesday unveiled a list of six designated “gatekeepers” set to come under its new Digital Markets Act.
Disney’s wildest ride: Iger, Chapek and the making of an epic succession mess
Here’s the inside story of the executive chaos at Disney over the past few years — and how it could shape the fate of the iconic entertainment company.
Apple buying Disney would be a storybook ending for Iger, but fairy tales aren’t real
Disney CEO Bob Iger may want to eventually sell Disney to Apple, but it’s unclear if Apple wants to buy Disney.
Here’s our second-quarter earnings report card for 34 stocks in the portfolio
We ranked the quarterly reports of our holdings in the Club as great, good, not-so-bad and ugly.
HSBC says this biopharma company can jump 25% despite ‘patent cliff’
HSBC initiated coverage on the drug treatment developer with a buy rating.
Blinken makes surprise trip to Kyiv as fatal blast hits Donetsk region
Ukraine was attacked with a barrage of drones and missiles overnight, officials said, with the capital Kyiv and the southern port of Odesa among the targets.
Evergrande soars 70% leading Chinese property stocks higher after Country Garden avoids default
The real estate sector was the top gainer on the HSI, but the overall index was still in negative territory, dragged by health-care and industrial stocks.
- « Previous Page
- 1
- …
- 313
- 314
- 315
- 316
- 317
- …
- 1899
- Next Page »